Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Methods Mol Biol ; 2057: 45-59, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-31595469

RESUMO

S-nitrosation as a redox-based posttranslational modification of protein cysteine has emerged as an integral part of signaling pathways of nitric oxide across all types of organisms. Protein S-nitrosation status is controlled by two key mechanisms: by direct denitrosation performed by the thioredoxin/thioredoxin reductase system, and in an indirect way mediated by S-nitrosoglutathione reductase (GSNOR). GSNOR, which has been identified as a key component of S-nitrosothiols catabolism, catalyzes an irreversible decomposition of abundant intracellular S-nitrosothiol, S-nitrosoglutathione (GSNO) to oxidized glutathione using reduced NADH cofactor. In plants, GSNOR has been shown to play important roles in plant growth and development and plant responses to abiotic and biotic stress stimuli. In this chapter, optimized protocols of spectrophotometric measurement of GSNOR enzymatic activity and activity staining in native polyacrylamide gels in plant GSNOR are presented.


Assuntos
Aldeído Oxirredutases/metabolismo , Ensaios Enzimáticos/métodos , Plantas/enzimologia , S-Nitrosotióis/metabolismo , Fluorescência , NAD/química , Eletroforese em Gel de Poliacrilamida Nativa , Óxido Nítrico/metabolismo , Nitrosação , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/metabolismo , S-Nitrosoglutationa/síntese química , S-Nitrosoglutationa/química , Coloração e Rotulagem/métodos , Fluxo de Trabalho
2.
Nitric Oxide ; 84: 30-37, 2019 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-30630056

RESUMO

Primary S-nitrosothiols (RSNOs) have received significant attention for their ability to modulate NO signaling in many physiological and pathophysiological processes. Such actions and their potential pharmaceutical uses demand a better knowledge of their stability in aqueous solutions. Herein, we investigated the effects of concentration, temperature, pH, room light and metal ions on the long-term kinetic behavior of two representative primary RSNOs, S-nitrosoglutathione (GSNO) and S-nitroso-N-acetylcysteine (SNAC). The thermal decomposition of GSNO and SNAC were shown to be affected by the auto-catalytic action of the thiyl radicals. At 25 °C in the dark and protected from the catalytic action of metal ions, GSNO and SNAC solutions 1 mM showed half-lives of 49 and 76 days, and apparent activation energies of 84 ±â€¯14 and 90 ±â€¯6 kJ mol-1, respectively. Both GSNO and SNAC exhibited increased stability in the pH range 5-7. At high pH the decomposition pathway of GSNO involves the formation of an intermediate (GS-NO22-), which decomposes generating GSH and nitrite. GSNO solutions displayed lower sensitivity to the catalytic action of metal ions than SNAC and the exposure to room light led to a 5-fold increase in the initial rates of decomposition of both RSNOs. In all comparisons, SNAC solutions showed higher stability than GSNO solutions. These findings provide strategic information about the stability of GSNO and SNAC and may open new perspectives for their use as experimental or therapeutic NO donors.


Assuntos
Acetilcisteína/análogos & derivados , S-Nitrosoglutationa/química , Acetilcisteína/síntese química , Acetilcisteína/química , Concentração de Íons de Hidrogênio , Cinética , Luz , S-Nitrosoglutationa/síntese química , Temperatura
3.
Nitric Oxide ; 84: 38-44, 2019 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-30639449

RESUMO

The entrapment of NO donors in nanomaterials has emerged as a strategy to protect these molecules from rapid degradation, allowing a more controlled release of NO and prolonging its effect. On the other hand, we have found beneficial effects of S-nitrosoglutathione (GSNO) - a NO donor - supplying to sugarcane plants under water deficit. Here, we hypothesized that GSNO encapsulated into nanoparticles would be more effective in attenuating the effects of water deficit on sugarcane plants as compared to the supplying of GSNO in its free form. The synthesis and characterization of chitosan nanoparticles containing GSNO were also reported. Sugarcane plants were grown in nutrient solution, and then subjected to the following treatments: control (well-hydrated); water deficit (WD); WD + GSNO sprayed in its free form (WDG) or encapsulated (WDG-NP). In general, both GSNO forms attenuated the effects of water deficit on sugarcane plants. However, the encapsulation of this donor into chitosan nanoparticles caused higher photosynthetic rates under water deficit, as compared to plants supplied with free GSNO. The root/shoot ratio was also increased when encapsulated GSNO was supplied, indicating that delayed release of NO improves drought tolerance of sugarcane plants. Our results provide experimental evidence that nanotechnology can be used for enhancing NO-induced benefits for plants under stressful conditions, alleviating the negative impact of water deficit on plant metabolism and increasing biomass allocation to root system.


Assuntos
Quitosana/química , Nanopartículas/química , Doadores de Óxido Nítrico/farmacologia , S-Nitrosoglutationa/farmacologia , Saccharum/efeitos dos fármacos , Estresse Fisiológico/efeitos dos fármacos , Biomassa , Preparações de Ação Retardada/química , Secas , Portadores de Fármacos/química , Doadores de Óxido Nítrico/síntese química , Fotossíntese/efeitos dos fármacos , Folhas de Planta/efeitos dos fármacos , Raízes de Plantas/efeitos dos fármacos , Brotos de Planta/efeitos dos fármacos , S-Nitrosoglutationa/síntese química
4.
Analyst ; 144(1): 180-185, 2018 Dec 17.
Artigo em Inglês | MEDLINE | ID: mdl-30379147

RESUMO

S-nitrosothiols (RSNOs) are very important biomolecules that play crucial roles in many physiological and physiopathological processes. They act as NO-donors and are candidates for future medicines. Their identification and quantitation are therefore important for biomedical applications. One, two or more RSNOs can then be combined to design a drug and therefore, the quantification of each is important to establish an acceptable quality control process. Till date, miniaturized devices have been used to detect RSNOs based on their total quantitation without a preceding separation step. This study reports on an original and integrated microdevice allowing for the successive electrokinetic separation of low molecular weight RSNOs, their decomposition under metal catalysis, and their quantitation by amperometric detection of the produced nitrite in the end-channel arrangement, leading to their quantitation in a single run. For this purpose, a commercial SU-8/Pyrex microfluidic system was coupled to a portable and wireless potentiostat. Different operating and running parameters were optimized to achieve the best analytical data, allowing for an LOD equal to 20 µM. The simultaneous separation of S-nitrosoglutathione and S-nitrosocysteine was successfully obtained within 75 s. The proposed methodology using SU-8/Pyrex microfluidic devices opens new possibilities to investigate future drug candidates for NO-donors.


Assuntos
Cisteína/análogos & derivados , Dispositivos Lab-On-A-Chip , Técnicas Analíticas Microfluídicas/métodos , S-Nitrosoglutationa/análise , S-Nitrosotióis/análise , Catálise , Cobre/química , Cisteína/análise , Cisteína/síntese química , Cisteína/química , Técnicas Eletroquímicas/instrumentação , Técnicas Eletroquímicas/métodos , Limite de Detecção , Técnicas Analíticas Microfluídicas/instrumentação , S-Nitrosoglutationa/síntese química , S-Nitrosoglutationa/química , S-Nitrosotióis/síntese química , S-Nitrosotióis/química
5.
Nitric Oxide ; 69: 10-21, 2017 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-28743484

RESUMO

Among S-nitrosothiols showing reversible binding between NO and -SH group, S-nitrosoglutathione (GSNO) represents potential therapeutics to treat cardiovascular diseases (CVD) associated with reduced nitric oxide (NO) availability. It also induces S-nitrosation of proteins, responsible for the main endogenous storage form of NO. Although oxidative stress parallels CVD development, little is known on the ability of GSNO to restore NO supply and storage in vascular tissues under oxidative stress conditions. Aortic rat smooth muscle cells (SMC) were stressed in vitro with a free radical generator (2,2'-azobis(2-amidinopropane) dihydrochloride, AAPH). The cellular thiol redox status was reflected through levels of reduced glutathione and protein sulfhydryl (SH) groups. The ability of GSNO to deliver NO to SMC and to induce protein S-nitrosation (investigated via mass spectrometry, MS), as well as the implication of two redox enzymes involved in GSNO metabolism (activity of gamma-glutamyltransferase, GGT, and expression of protein disulfide isomerase, PDI) were evaluated. Oxidative stress decreased both intracellular glutathione and protein -SH groups (53% and 32% respectively) and caused a 3.5-fold decrease of GGT activity, while PDI expression at the plasma membrane was 1.7-fold increased without any effect on extracellular GSNO catabolism. Addition of GSNO (50 µM) increased protein -SH groups and protein S-nitrosation (50%). Mass spectrometry analysis revealed a higher number of S-nitrosated proteins under oxidative stress (83 proteins, vs 68 in basal conditions) including a higher number of cytoskeletal proteins (15, vs 9 in basal conditions) related with cell contraction, morphogenesis and movement. Furthermore, proteins belonging to additional protein classes (cell adhesion, transfer/carrier, and transporter proteins) were S-nitrosated under oxidative stress. In conclusion, higher levels of GSNO-dependent S-nitrosation of proteins from the cytoskeleton and the contractile machinery were identified under oxidative stress conditions. The findings may prompt the identification of suitable biomarkers for the appraisal of GSNO bioactivity in the CVD treatment.


Assuntos
Músculo Liso Vascular/fisiologia , Nitratos/química , Doadores de Óxido Nítrico/farmacologia , Estresse Oxidativo/fisiologia , S-Nitrosoglutationa/farmacologia , Amidinas/farmacologia , Animais , Glutationa/metabolismo , Proteínas Musculares/metabolismo , Doadores de Óxido Nítrico/síntese química , Nitrosação , Oxirredução , Estresse Oxidativo/efeitos dos fármacos , Isomerases de Dissulfetos de Proteínas/metabolismo , Ratos , S-Nitrosoglutationa/síntese química , Compostos de Sulfidrila/metabolismo , gama-Glutamiltransferase/metabolismo
6.
Bioorg Med Chem ; 21(24): 7853-7, 2013 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-24184214

RESUMO

Aromatic and aliphatic nitrosamines are known to transfer a nitrosonium ion to another amine. The transnitrosation of alicyclic N-nitroso compounds generates S-nitrosothiols, which are potential nitric oxide donors in vivo. In this study, certain alicyclic N-nitroso compounds based on non-mutagenic N-nitrosoproline or N-nitrosothioproline were synthesised, and the formation of S-nitrosoglutathione (GSNO) was quantified under acidic conditions. We then investigated the effect of a sulfur atom as the substituent and as a ring component on the GSNO formation. In the presence of thiourea under acidic conditions, GSNO was formed from N-nitrosoproline and glutathione, and an N-nitroso compound containing a sulfur atom and glutathione produced GSNO without thiourea. The quantity of GSNO derived from the reaction of the N-nitrosamines containing a sulfur atom and glutathione was higher than that from the N-nitrosoproline and glutathione plus thiourea. Among the analogues that contained a sulfur atom either in the ring or as a substituent, the thiazolidines produced a slightly higher quantity of GSNO than the analogue with a thioamide group. A compound containing sulfur atoms both in the ring and as a substituent exhibited the highest activity for GSNO formation among the alicyclic N-nitrosamines tested. The results indicate that the intramolecular sulfur atom plays an important role in the transnitrosation via alicyclic N-nitroso compounds to form GSNO.


Assuntos
Nitrosaminas/química , Enxofre/química , Estrutura Molecular , S-Nitrosoglutationa/síntese química , S-Nitrosoglutationa/química
7.
Biosci Trends ; 5(1): 17-22, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21422596

RESUMO

Histone deacetylase (HDAC) 8 is a zinc ion dependent enzyme involved in removing the acetyl group from the core histones and other proteins which belong to Class I HDACs. It was reported that nitric oxide (NO) is a key regulator of HDAC function and S-nitrosylation of HDAC2 induces chromatin remodelling in neurons. This work reports the successful recombinant expression of human HDAC8 in Escherichia coli with two plasmids and the purification and S-nitrosylation in vitro. It was found that HDAC8 can be S-nitrosylated by the NO donor S-nitrosoglutathione (GSNO) in vitro, and the activity of HDAC8 was significantly inhibited when incubated with GSNO and S-nitrosocysteine in a time- and dosage-dependent manner, but sodium nitroprusside (SNP), and dithiothreitol cannot reverse this inhibition. These observations support and extend the concept that NO may regulate HDAC8 function by S-nitrosylation.


Assuntos
Histona Desacetilases/isolamento & purificação , Histona Desacetilases/metabolismo , Óxido Nítrico/metabolismo , Proteínas Recombinantes/metabolismo , Proteínas Repressoras/isolamento & purificação , Proteínas Repressoras/metabolismo , S-Nitrosoglutationa/metabolismo , Western Blotting , Cisteína/análogos & derivados , Cisteína/síntese química , Cisteína/metabolismo , Primers do DNA/genética , Eletroforese em Gel de Poliacrilamida , Escherichia coli , Humanos , Técnicas In Vitro , Plasmídeos/genética , S-Nitrosoglutationa/síntese química , S-Nitrosotióis/síntese química , S-Nitrosotióis/metabolismo
8.
Appl Radiat Isot ; 67(1): 95-9, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19019692

RESUMO

In the present paper, a fast and reproducible method for the synthesis of S-[(13)N]nitrosoglutathione is reported for the first time. The labeling strategy is based on the production of [(13)N]NO(3)(-) via the (16)O(p,alpha)(13)N nuclear reaction in water, as opposed to the standardized production of [(13)N]NH(4)(+) in 2mM aqueous ethanol. Following the reduction of [(13)N]NO(3)(-) to [(13)N]NO(2)(-), the reaction with glutathione in the presence of hydrochloric acid led to the desired radiotracer with a good radiochemical yield (24.2+/-2.0% end of synthesis, n=5) in a short production time (3min from the end of bombardment).


Assuntos
Marcação por Isótopo/métodos , Radioisótopos de Nitrogênio , Tomografia por Emissão de Pósitrons/métodos , Compostos Radiofarmacêuticos/síntese química , S-Nitrosoglutationa , S-Nitrosoglutationa/síntese química , Soluções , Água
9.
Biol Pharm Bull ; 31(8): 1536-40, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18670085

RESUMO

Protein S-nitrosylation in the heart tissue has been implicated in several patho (physiological) processes. However, specific protein targets for S-nitrosylation remain largely unknown. In this study, the rat cardiac proteins were incubated in vitro with S-nitrosoglutathione (GSNO), a biologically existing nitric oxide (NO) donor and S-nitrosating agent, to induce protein S-nitrosylation, and the resulting S-nitrosylated proteins were purified by the biotin switch method, followed by two-dimensional gel electrophoresis (2-DE) separation and matrix-assisted laser desorption ionization/time of flight tandem mass spectrometry (MALDI-TOF-MS/MS) identification. Candidate Western blot analysis was also used to identify potential S-nitrosylated proteins. A total of ten proteins including triosephosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, creatine kinase, adenylate kinase 1 (AK1), enolase 1, destrin, actin, myosin, albumin and Hsp27 were unambiguously identified, among which AK1 was found as a novel target of S-nitrosylation. Further studies showed that AK1 activity in the rat heart extracts was significantly inhibited by GSNO but not oxidized glutathione (GSSG), and the inhibition was completely reversed by dithiothreitol (DTT) post-treatment, demonstrating that S-nitrosylation might serve as a new regulatory mechanism in controlling AK1 activity. This study represents an initial attempt to characterize the S-nitrosoproteome in the heart and highlights the importance of protein S-nitrosylation in cardio function regulation.


Assuntos
Proteínas Musculares/genética , Miocárdio/metabolismo , Compostos Nitrosos/metabolismo , Proteômica/métodos , Adenilato Quinase/metabolismo , Animais , Western Blotting , Bases de Dados Factuais , Ditiotreitol/farmacologia , Eletroforese em Gel Bidimensional , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Técnicas In Vitro , Masculino , Proteínas Musculares/metabolismo , Doadores de Óxido Nítrico/farmacologia , Ratos , Ratos Sprague-Dawley , S-Nitrosoglutationa/síntese química , S-Nitrosoglutationa/farmacologia , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Reagentes de Sulfidrila/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...